145 related articles for article (PubMed ID: 28628136)
1. [Effects of equol on colon cancer cell proliferation].
Cai YF; Zhang HM; Niu WY; Zou YQ; Ma DF
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):383-387. PubMed ID: 28628136
[TBL] [Abstract][Full Text] [Related]
2. [Effects of equol on proliferation of colorectal cancer HCT-15 cell].
Zou Y; Wang Y; Cai Y; Ma D
Wei Sheng Yan Jiu; 2019 Sep; 48(5):803-806. PubMed ID: 31601322
[TBL] [Abstract][Full Text] [Related]
3. Functional estrogen receptor beta in colon cancer cells.
Fiorelli G; Picariello L; Martineti V; Tonelli F; Brandi ML
Biochem Biophys Res Commun; 1999 Aug; 261(2):521-7. PubMed ID: 10425218
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein.
Arai N; Ström A; Rafter JJ; Gustafsson JA
Biochem Biophys Res Commun; 2000 Apr; 270(2):425-31. PubMed ID: 10753641
[TBL] [Abstract][Full Text] [Related]
7. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
Zhao X; Li X; Ren Q; Tian J; Chen J
Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
[TBL] [Abstract][Full Text] [Related]
8. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation of estrogen receptor alpha and beta gene expression in human granulosa-luteal cells in vitro.
Chiang CH; Cheng KW; Igarashi S; Nathwani PS; Leung PC
J Clin Endocrinol Metab; 2000 Oct; 85(10):3828-39. PubMed ID: 11061546
[TBL] [Abstract][Full Text] [Related]
10. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
11. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity.
Shinkaruk S; Carreau C; Flouriot G; Bennetau-Pelissero C; Potier M
Nutrients; 2010 Mar; 2(3):340-54. PubMed ID: 22254026
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens.
Kelly LA; Seidlova-Wuttke D; Wuttke W; O'Leary JJ; Norris LA
Phytomedicine; 2014 Jan; 21(2):155-8. PubMed ID: 23972791
[TBL] [Abstract][Full Text] [Related]
15. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.
Powell E; Shanle E; Brinkman A; Li J; Keles S; Wisinski KB; Huang W; Xu W
PLoS One; 2012; 7(2):e30993. PubMed ID: 22347418
[TBL] [Abstract][Full Text] [Related]
16. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
Ni YD; Hong WJ; Zhou YC; Grossmann R; Zhao RQ
Steroids; 2010 Mar; 75(3):245-51. PubMed ID: 20043933
[TBL] [Abstract][Full Text] [Related]
18. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
[TBL] [Abstract][Full Text] [Related]
19. ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components.
Martineti V; Picariello L; Tognarini I; Carbonell Sala S; Gozzini A; Azzari C; Mavilia C; Tanini A; Falchetti A; Fiorelli G; Tonelli F; Brandi ML
Endocr Relat Cancer; 2005 Jun; 12(2):455-69. PubMed ID: 15947116
[TBL] [Abstract][Full Text] [Related]
20. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]